Pharmacologic Prevention of Stroke Jonathan Raser-Schramm, MD, PhD Medical Director, Stroke Program Christiana Care Health System March 21, 2014.
Agent Orange and End Organ Disease My experiences as a veteran, patient, and a health care provider. Hans White, PA-C.
The imminent NICE guidelines for AF – what are the implications? David Hargroves, Consultant Physician, Clinical Lead for Stroke Medicine, East Kent Hospitals.
Vasculitides constitute a spectrum of diseases characterized by inflammation & necrosis of blood vessels with resulting ischemia of those tissues.
IC Bypass Study
